These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3741910)

  • 1. Body weight and reported versus measured weight loss as confounders of the dexamethasone suppression test.
    Pfohl B; Coryell W; Stangl D; Zimmerman M
    Biol Psychiatry; 1986 Aug; 21(10):931-8. PubMed ID: 3741910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Parker CR; Weissenburger JE; Crowley GT; Khatami M; Vasavada N
    J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between post-dexamethasone cortisol level and blood pressure in depressed inpatients.
    Pfohl B; Rederer M; Coryell W; Stangl D
    J Nerv Ment Dis; 1991 Jan; 179(1):44-7. PubMed ID: 1985149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone suppression test response in major depression: stability across hospitalizations.
    Coryell W; Schlesser MA
    Psychiatry Res; 1983 Mar; 8(3):179-89. PubMed ID: 6574537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of early and delayed inpatient dexamethasone suppression tests.
    Haskett RF; Zis AP; Albala AA; Lohr NE; Carroll BJ
    Psychiatry Res; 1989 Feb; 27(2):161-71. PubMed ID: 2710864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measured weight loss and the dexamethasone suppression test.
    Kennedy SH; Garfinkel PE; Stokl S; Whynot CA
    Can J Psychiatry; 1989 Oct; 34(7):707-9. PubMed ID: 2804882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial dexamethasone suppression tests in psychiatric illness: Part III. The influence of intervening variables.
    Baumgartner A; Haack D; Vecsei P
    Psychiatry Res; 1986 May; 18(1):45-64. PubMed ID: 3737787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic heterogeneity and the DST in consecutive psychiatric admissions.
    Keitner GI; Haier RJ; Qualls CB; Brown WA; McKendall MJ
    Psychiatry Res; 1985 Mar; 14(3):215-23. PubMed ID: 3858894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the dexamethasone suppression test in psychiatric patients with and without weight loss.
    Keitner GI; Brown WA; Qualls CB; Haier RJ; Barnes KT
    Am J Psychiatry; 1985 Feb; 142(2):246-8. PubMed ID: 3970250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone suppression test and the levels of serum growth hormone, plasma vasopressin and plasma homovanillic acid in depressed in- and outpatients.
    Syvälahti E
    Acta Psychiatr Scand; 1985 Feb; 71(2):105-10. PubMed ID: 3976406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of concurrent medical illness on dexamethasone suppression test results in depressed inpatients.
    Cooke RG; Warsh JJ; Stancer HC; Hasey GM; Jorna T; Langlet F
    Can J Psychiatry; 1990 Feb; 35(1):31-5. PubMed ID: 2317731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test and quantitative cerebral anatomy in depression.
    Coffey CE; Wilkinson WE; Weiner RD; Ritchie JC; Aque M
    Biol Psychiatry; 1993 Mar; 33(6):442-9. PubMed ID: 8490071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression and dexamethasone suppression testing in children and adolescents.
    Emslie GJ; Weinberg WA; Rush AJ; Weissenburger J; Parkin-Feigenbaum L
    J Child Neurol; 1987 Jan; 2(1):31-7. PubMed ID: 3624827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone suppression test in dementia: a review of the literature.
    Skare S; Pew B; Dysken M
    J Geriatr Psychiatry Neurol; 1990; 3(3):124-38. PubMed ID: 2282129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An American validation study of the Newcastle diagnostic scale. I. Relationship with the dexamethasone suppression test.
    Zimmerman M; Pfohl B; Stangl D; Coryell W
    Br J Psychiatry; 1986 Nov; 149():627-30. PubMed ID: 3814955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement.
    Holsboer F; Liebl R; Hofschuster E
    J Affect Disord; 1982 Jun; 4(2):93-101. PubMed ID: 6213695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone suppression test in psychiatric patients with psychoactive substance dependence.
    Olivera AA; Fero D; Scibilia J
    Am J Drug Alcohol Abuse; 1991 Sep; 17(3):295-305. PubMed ID: 1928023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test and completed suicide.
    Norman WH; Brown WA; Miller IW; Keitner GI; Overholser JC
    Acta Psychiatr Scand; 1990 Feb; 81(2):120-5. PubMed ID: 2327273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological 'markers' for endogenous depression. Effect of age, severity of illness, weight loss, and polarity.
    Feinberg M; Carroll BJ
    Arch Gen Psychiatry; 1984 Nov; 41(11):1080-5. PubMed ID: 6497570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.